KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Net Income (2016 - 2025)

Historic Net Income for Elevance Health (ELV) over the last 16 years, with Q4 2025 value amounting to $546.0 million.

  • Elevance Health's Net Income rose 3220.34% to $546.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.7 billion, marking a year-over-year decrease of 519.18%. This contributed to the annual value of $5.7 billion for FY2025, which is 519.18% down from last year.
  • According to the latest figures from Q4 2025, Elevance Health's Net Income is $546.0 million, which was up 3220.34% from $1.2 billion recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Net Income registered a high of $2.3 billion during Q2 2024, and its lowest value of $413.0 million during Q4 2024.
  • Its 5-year average for Net Income is $1.5 billion, with a median of $1.6 billion in 2022.
  • Per our database at Business Quant, Elevance Health's Net Income surged by 57657.66% in 2021 and then tumbled by 5030.08% in 2024.
  • Elevance Health's Net Income (Quarter) stood at $1.2 billion in 2021, then fell by 25.61% to $877.0 million in 2022, then fell by 5.25% to $831.0 million in 2023, then tumbled by 50.3% to $413.0 million in 2024, then surged by 32.2% to $546.0 million in 2025.
  • Its Net Income stands at $546.0 million for Q4 2025, versus $1.2 billion for Q3 2025 and $1.7 billion for Q2 2025.